{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:24Z","timestamp":1792784004437,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Innovative Economy Programme","award":["POIG.01.01.02-00-069\/09"],"award-info":[{"award-number":["POIG.01.01.02-00-069\/09"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.intimp.2015.04.053","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T09:56:26Z","timestamp":1431338186000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Magdalena","family":"Sternak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Czarnowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa M.","family":"Slominska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard T.","family":"Smolenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jasztal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Chlopicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.04.053_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.bjp.0707383","article-title":"1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2\/prostacyclin pathway","volume":"152","author":"Chlopicki","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0010","first-page":"127","article-title":"1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats","volume":"60","author":"Bartu\u015b","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2015.04.053_bb0015","first-page":"109","article-title":"1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin","volume":"55","author":"Gebicki","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2230.2005.01908.x","article-title":"Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study","volume":"30","author":"Wozniacka","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejphar.2007.09.011","article-title":"Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin","volume":"578","author":"Bryniarski","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0030","first-page":"105","article-title":"Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress\u202f: role of endogenous prostacyclin and sensory nerves","volume":"326","author":"Brzozowski","year":"2008"},{"key":"10.1016\/j.intimp.2015.04.053_bb0035","first-page":"69","volume":"46","author":"Slomka","year":"2008"},{"key":"10.1016\/j.intimp.2015.04.053_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2008-1666","article-title":"Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells","volume":"68","author":"Slomka","year":"2008","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.intimp.2015.04.053_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuint.2009.10.004","article-title":"1-Methylnicotinamide (MNA) in prevention of diabetes-associated brain disorders","volume":"56","author":"Kuchmerovska","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.intimp.2015.04.053_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1734-1140(09)70010-6","article-title":"Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats","volume":"61","author":"Wata\u0142a","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2015.04.053_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020070047","article-title":"N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test","volume":"107","author":"Aoyama","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.intimp.2015.04.053_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033291700013817","article-title":"N-methylnicotinamide excretion and affective disorders","volume":"6","author":"Cazzullo","year":"1976","journal-title":"Psychol. Med."},{"key":"10.1016\/j.intimp.2015.04.053_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0009-8981(77)90206-6","article-title":"Metabolism of nicotinic acid in children with burns and scalds","volume":"75","author":"Barlow","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2015.04.053_bb0070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1572-0241.2001.03698.x","article-title":"The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production","volume":"96","author":"Pumpo","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1734-1140(09)70009-X","article-title":"Activation of nicotinamide N-methyltransferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis","volume":"61","author":"Mateuszuk","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2015.04.053_bb0080","first-page":"2","article-title":"Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma","volume":"3","author":"Sartini","year":"2007"},{"key":"10.1016\/j.intimp.2015.04.053_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1756-9966-28-20","article-title":"Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis","volume":"28","author":"Kim","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2015.04.053_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/emm.2006.54","article-title":"Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification","volume":"38","author":"Lim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2015.04.053_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.04.053_bb0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0378-4347(00)82125-8","article-title":"Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation","volume":"527","author":"Smolenski","year":"1990","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.intimp.2015.04.053_bb0105","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/15257770600894725","article-title":"Liquid chromatographic\/mass spectrometric procedure for measurement of NAD catabolites in human and rat plasma and urine","volume":"25","author":"Slominska","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.intimp.2015.04.053_bb0110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jchromb.2010.02.009","article-title":"Simultaneous determination of nicotinic acid and its four metabolites in rat plasma using high performance liquid chromatography with tandem mass spectrometric detection (LC\/MS\/MS)","volume":"878","author":"Szafarz","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.intimp.2015.04.053_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/tx060228l","article-title":"Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury\u2020","volume":"20","author":"Bourdi","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0120","first-page":"290","article-title":"Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling","volume":"2011","author":"Malchow","year":"1812","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2015.04.053_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jlb.67.1.90","article-title":"Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice","volume":"67","author":"Tagawa","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0130","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6","volume":"179","author":"Mizuhara","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2015.04.053_bb0135","first-page":"1608","article-title":"Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis","volume":"23","author":"Mizuhara","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2015.04.053_bb0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0168-8278(95)80206-1","article-title":"Nicotinamide methylation and hepatic energy reserve: a study by liver perfusion in vitro","volume":"23","author":"Cuomo","year":"1995","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2015.04.053_bb0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0304-4165(84)90074-6","article-title":"Nicotinamide methylation and its relation to NAD synthesis in rat liver tissue culture. Biochemical basis for the physiological activities of 1-methylnicotinamide","volume":"801","author":"Hoshino","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2015.04.053_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/BJ20101685","article-title":"The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors","volume":"436","author":"Parsons","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2015.04.053_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/61.2.111","article-title":"Expression of nicotinamide n\u2010methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain","volume":"61","author":"Parsons","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.radonc.2011.05.086","article-title":"Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance","volume":"99","author":"D'Andrea","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.200906-0936OC","article-title":"Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease","volume":"181","author":"Kim","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2015.04.053_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.molmet.2013.02.002","article-title":"Neuronal ROS signaling rather than AMPK\/sirtuin-mediated energy sensing links dietary restriction to lifespan extension","volume":"2","author":"Schmeisser","year":"2013","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.intimp.2015.04.053_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1734-1140(10)70304-2","article-title":"Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse","volume":"62","author":"Sternak","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2015.04.053_bb0180","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.4049\/jimmunol.0901045","article-title":"Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP\/p300 to STAT1 in a SOCS-1-independent manner","volume":"183","author":"Strassheim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.04.053_bb0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1478-3231.2005.01143.x","article-title":"Beraprost sodium, a prostacyclin (PGI2) analogue, ameliorates concanavalin A-induced liver injury in mice","volume":"25","author":"Ohta","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2015.04.053_bb0190","first-page":"226","article-title":"Iloprost, a prostacyclin (PGI 2) analogue, reduces liver injury in hepatic ischemia\u2014Iloprost, um an\u00e1logo da prostaciclina (PGI 2), reduz danos da isquemia\/reperfus\u00e3o hep\u00e1tica em ratos","volume":"24","author":"Gediki","year":"2009"},{"key":"10.1016\/j.intimp.2015.04.053_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0024-3205(94)00404-8","article-title":"Decreased prostacyclin production by liver non-parenchymal cells precedes liver injury in experimental alcoholic liver disease","volume":"54","author":"Nanji","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2015.04.053_bb0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3748\/wjg.v11.i2.232","article-title":"Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure","volume":"11","author":"Chu","year":"2005","journal-title":"World J. Gastroenterol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:35:54Z","timestamp":1755650154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1567576915002179"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.04.053","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}